학술논문
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial
Document Type
Article
Author
Ahmad, Saleem; Alexandru, Sofia; Bellenger, Katharine; Bulga, Tolera G.; Cook, Claire; Crudu, Valeriu; Deborah, Bennet; Dodds, Wendy; Gebreegziabher, Belay A.; Goodall, Ruth L.; Gupta, Pritti; Gurumurthy, Meera; Langley, Ivor; Nalunjogi, Joanitah; Khan, Saleem; Krishnan, Saravanan; Kumar, Shravan; Lesosky, Maia; Macari, Mariana; Makwana, Mukesh; Murphy, Brendan; Murugesan, Ramesh P.; Patel, Vanita; Pirlog, Irina; Rauchenberger, Mary; Sanders, Karen; Singh, Ramesh; Subramani, Sangeetha; Teferi, Mekonnen; Tegegn, Netsanet A.; Velmurugan, Arun Babu; Whitney, Johanna; Rosu, Laura ; Madan, Jason J; Tomeny, Ewan M; Muniyandi, Malaisamy; Nidoi, Jasper; Girma, Mamo; Vilc, Valentina; Bindroo, Priyanka; Dhandhukiya, Rajdeep; Bayissa, Adamu K; Meressa, Daniel; Narendran, Gopalan; Solanki, Rajesh; Bhatnagar, Anuj K; Tudor, Elena; Kirenga, Bruce; Meredith, Sarah K; Nunn, Andrew J; Bronson, Gay; Rusen, I D; Squire, S Bertel ; Worrall, Eve
Source
In The Lancet Global Health February 2023 11(2):e265-e277
Subject
Language
ISSN
2214-109X